4-Chloro-1H-imidazo[4,5-c]pyridine - CAS 2770-01-6
Catalog: |
BB019652 |
Product Name: |
4-Chloro-1H-imidazo[4,5-c]pyridine |
CAS: |
2770-01-6 |
Synonyms: |
4-chloro-1H-imidazo[4,5-c]pyridine; 4-chloro-1H-imidazo[4,5-c]pyridine |
IUPAC Name: | 4-chloro-1H-imidazo[4,5-c]pyridine |
Description: | 4-Chloro-1H-imidazo[4,5-c]pyridine (CAS# 2770-01-6) is used as a reagent in the synthesis of 3-bromo-3-deazaneplanocin and 3-bromo-3-deazaaristeromycin, compounds which exhibit antiviral activity. |
Molecular Weight: | 153.57 |
Molecular Formula: | C6H4ClN3 |
Canonical SMILES: | C1=CN=C(C2=C1NC=N2)Cl |
InChI: | InChI=1S/C6H4ClN3/c7-6-5-4(1-2-8-6)9-3-10-5/h1-3H,(H,9,10) |
InChI Key: | DHJMLXBBZRWBPW-UHFFFAOYSA-N |
Boiling Point: | 455.4 °C at 760 mmHg |
Density: | 1.531 g/cm3 |
MDL: | MFCD08689582 |
LogP: | 1.61130 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-113512042-A | Substituted quinazoline-4-ketone compound and preparation method and application thereof | 20200409 |
WO-2021123294-A1 | Oga inhibitor compounds | 20191218 |
WO-2020210649-A1 | Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors | 20190412 |
TW-202103708-A | Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors | 20190412 |
TW-202003471-A | SHP2 phosphatase inhibitors and methods of use thereof | 20180321 |
PMID | Publication Date | Title | Journal |
22795626 | 20120815 | 3-Bromo-3-deazaneplanocin and 3-bromo-3-deazaaristeromycin: synthesis and antiviral activity | Bioorganic & medicinal chemistry letters |
7699695 | 19950317 | 3-deaza- and 7-deaza-5'-noraristeromycin and their antiviral properties | Journal of medicinal chemistry |
Complexity: | 130 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 153.0093748 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 153.0093748 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 41.6 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.4 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Imidazopyridines
Customers Also Viewed
-
[33229-34-4]
2,2'-[4-(2-Hydroxyethylamino)-3-nitrophenylimino]diethanol
-
[133407-82-6]
MG-132
-
[875573-66-3]
Estra-1,3,5(10)-triene-3,17-diol,7-(9-bromononyl)-,17-acetate,(7a,17b)-
-
[44994-28-7]
N,N,N',N'-Tetramethyl-1,5-pentanediamine
-
[597-35-3]
ethylsulfone
-
[2555-49-9]
Ethyl phenoxyacetate
INDUSTRY LEADERS TRUST OUR PRODUCTS